Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2– breast cancer treated with CDK4/6 inhibitors and endocrine therapy

Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2– breast cancer treated with CDK4/6 inhibitors and endocrine therapy

Background: Advanced breast cancer (ABC) is characterized by multidimensional clinical complexity that is usually not considered in randomized clinical trials. In the present real-life study, we investigated the link between clinical complexity and quality of life of patients with HR+/HER2– ABC trea...

Full description

Bibliographic Details
Main Authors: Barbara Tagliaferri, Ludovica Mollica, Raffella Palumbo, Claudia Leli, Alberto Malovini, Matteo Terzaghi, Erica Quaquarini, Cristina Teragni, Stefano Maccarone, Andrea Premoli, Federico Sottotetti
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2023-01-01
Series:Drugs in Context
Subjects:
breast cancer
cdk4/6 inhibitors
clinical complexity
comorbidities
polypharmacy
quality of life
real-life population
Online Access:https://www.drugsincontext.com/health-related-quality-of-life-and-clinical-complexity-of-a-real-life-cohort-of-patients-with-advanced-hr-her2-breast-cancer-treated-with-cdk4-6-inhibitors-and-endocrine-therapy

Internet

https://www.drugsincontext.com/health-related-quality-of-life-and-clinical-complexity-of-a-real-life-cohort-of-patients-with-advanced-hr-her2-breast-cancer-treated-with-cdk4-6-inhibitors-and-endocrine-therapy

Similar Items